Analgesics in Belarus
COVID-19 stimulated a high demand for analgesics in Belarus, particularly acetaminophen. Medical professionals have been advising patients to take paracetamol in case of high fever. Unlike in the early stages of the pandemic in the previous year, there is no stockpiling in 2021, and no shortages of acetaminophen as a result.
Euromonitor International's Analgesics in Belarus report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Analgesics in Belarus report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
ANALGESICS IN BELARUS
KEY DATA FINDINGS
2021 DEVELOPMENTS
After a peak in the early stages of the COVID-19 pandemic, demand for acetaminophen normalises in 2021
Healthy living Belarusians expected to turn to natural remedies over the prolonged use of analgesics
State-owned domestic player, Borisovskiy Zavod Meditsinkikh Preparatov, maintains competitive advantage
PROSPECTS AND OPPORTUNITIES
Opportunities for domestic brands to gain shares with expanded portfolios
Adult combined analgesics shows scope for development in the time of COVID-19 and beyond
Topical analgesics/anaesthetic not to be overlooked, as competition between players remains strong
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN BELARUS
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Distribution of Consumer Health by Format: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format and Category: % Value 2021
Table 15 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
KEY DATA FINDINGS
2021 DEVELOPMENTS
After a peak in the early stages of the COVID-19 pandemic, demand for acetaminophen normalises in 2021
Healthy living Belarusians expected to turn to natural remedies over the prolonged use of analgesics
State-owned domestic player, Borisovskiy Zavod Meditsinkikh Preparatov, maintains competitive advantage
PROSPECTS AND OPPORTUNITIES
Opportunities for domestic brands to gain shares with expanded portfolios
Adult combined analgesics shows scope for development in the time of COVID-19 and beyond
Topical analgesics/anaesthetic not to be overlooked, as competition between players remains strong
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN BELARUS
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Distribution of Consumer Health by Format: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format and Category: % Value 2021
Table 15 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
